In a previous study of stage III melanoma, our tissue microarray analysis demonstrated that high mPGES1 staining intensity was significantly associated with low CD8 levels, and we found that patients whose tumors had a high-mPGES1, low-CD8 expression signature had a significantly increased risk of death (31). This evidence concerns the gene CD8A and melanoma.